- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Diabetic Patients With Polyneuropathy in South Africa
Total 28 results
-
Qurient Co., Ltd.CompletedTreatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TBSouth Africa
-
Bio-Thera SolutionsGeorge Clinical Pty LtdActive, not recruiting
-
Johnson & Johnson Pharmaceutical Research & Development...Grünenthal GmbHTerminatedDiabetic Neuropathy, Painful | Diabetic PolyneuropathyUnited States
-
Sangamo TherapeuticsJuvenile Diabetes Research FoundationCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Diabetic PolyneuropathyUnited States
-
Samsung Medical CenterUnknownPatients With Acute Myeloid Leukemia | Patients Receiving Induction/Consolidation ChemotherapyKorea, Republic of
-
Sheffield Teaching Hospitals NHS Foundation TrustTerminatedPatients With Coeliac Disease and Chronic Diarrhoea (>3 Loose/ Liquid Motions a Day for More Than 4 Weeks) | Patients With Pancreatic Exocrine InsufficiencyUnited Kingdom
-
AstraZenecaCompletedInvestigation of Platelet Aggregation in Paediatric Patients With Sickle Cell DiseaseUnited States, Canada, United Kingdom, South Africa, Lebanon, Kenya
-
Calliditas Therapeutics ABCompletedType 2 Diabetes Mellitus With Diabetic NephropathyAustralia, United States, Germany, Poland, Canada, Czech Republic
-
Akebia TherapeuticsCyclerion TherapeuticsCompletedType 2 Diabetes Mellitus With Diabetic NephropathyUnited States
-
Jazz PharmaceuticalsCompletedPatients With Severe Chronic PainUnited States
-
Par Pharmaceutical, Inc.Novum Pharmaceutical Research ServicesTerminatedOtitis Media in Patients With Tympanostomy TubesUnited States
-
The Queen Elizabeth HospitalLyell McEwin HospitalUnknownCOPD | Obstructive Sleep Apnoea | Patients With Anxiety and Depression, Who HaveAustralia
-
AstraZenecaCompletedPatients With Opioid Induced ConstipationCanada, United States
-
PfizerTerminatedAvelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid TumorsUnited States, Canada, United Kingdom, Korea, Republic of, Australia, Belgium, Denmark, Hungary, Russian Federation
-
Ripple Therapeutics Pty LtdNovotech (Australia) Pty LimitedActive, not recruitingDiabetic Macular Oedema | Retinal Vein Occlusion With Macular OedemaAustralia, New Zealand, Hong Kong, Canada
-
Innate PharmaCompletedPatients With Multiple Myeloma Experiencing a | First or Second RelapseUnited States
-
AstraZenecaCompletedChildren and Adolescent With Type 2 DiabetesUnited States, Hungary, Israel, Mexico, Bulgaria, Ukraine, Kuwait
-
PfizerCompletedMacular Edema Associated With Diabetes MellitusUnited States, Colombia, Australia, Germany, Italy, South Africa, Greece, France, Austria, United Kingdom, Denmark, India, Portugal, Brazil, Canada, Czechia, Netherlands, Switzerland
-
Novartis PharmaceuticalsCompletedHyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement TherapyGermany, United Kingdom, Italy, Belgium, Sweden, Canada, United States, Australia, Finland, France, Norway, Puerto Rico, Switzerland
-
BioMarin PharmaceuticalTerminatedLate-onset Pompe Patients Untreated or Treated With rhGAASpain, Slovenia, Serbia, Korea, Republic of, Greece, Australia, Singapore, Brazil, Canada, Taiwan, Ireland, Poland, Romania
-
Taiho Oncology, Inc.CompletedBreast Cancer | Gastric Cancer | Cholangiocarcinoma | Urothelial Cancer | Primary CNS Tumors | Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR TumorsFrance, United States, Korea, Republic of, United Kingdom, Japan, Hong Kong, Australia, Taiwan, Italy, Canada, Germany, Netherlands, Spain
-
UK Kidney AssociationRecruitingVasculitis | AL Amyloidosis | Tuberous Sclerosis | Fabry Disease | Cystinuria | Focal Segmental Glomerulosclerosis | IgA Nephropathy | Bartter Syndrome | Pure Red Cell Aplasia | Membranous Nephropathy | Atypical Hemolytic Uremic Syndrome | Autosomal Dominant Polycystic Kidney Disease | Cystinosis | Nephronophthisis | BK Nephropathy and other conditionsUnited Kingdom
-
Genzyme, a Sanofi CompanyCompletedAlport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2France, Germany, Australia, United States, United Kingdom, Canada
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAgitation in Patients With Dementia of the Alzheimer's TypeSpain, United States, Italy, United Kingdom, Hungary, France, Poland, Australia, Bulgaria, Czechia, South Africa
-
Otsuka Pharmaceutical Development & Commercialization...RecruitingAgitation in Patients With Dementia of the Alzheimer's TypeUnited States, Spain, Hungary, Italy, Canada, Czechia, South Africa, Bulgaria, France, Poland
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAgitation in Patients With Dementia of the Alzheimer's TypeUnited States, Estonia, Germany, Poland, Portugal, Puerto Rico
-
Otsuka Pharmaceutical Development & Commercialization...RecruitingAgitation in Patients With Dementia of the Alzheimer's TypeUnited States, Belgium, Canada, Chile, Colombia, Croatia, Hungary, Mexico, Netherlands, Slovakia, Slovenia, Spain, Ireland
-
Sanford HealthNational Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research... and other collaboratorsRecruitingMitochondrial Diseases | Retinitis Pigmentosa | Myasthenia Gravis | Eosinophilic Gastroenteritis | Multiple System Atrophy | Leiomyosarcoma | Leukodystrophy | Anal Fistula | Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Kennedy Disease | Lyme Disease | Hemophagocytic Lymphohistiocytosis | Spinocerebellar Ataxia... and other conditionsUnited States, Australia